期刊文献+

经尿道切除膀胱多发肿瘤和巨大肿瘤

Transurethral resection of multiple and/or huge bladder tumors
暂未订购
导出
摘要 目的:探讨经尿道切除膀胱多发肿瘤和巨大肿瘤的治疗效果。方法:采用经尿道膀胱肿瘤切除(TUR-BT)手术治疗29例膀胱多发肿瘤和/或巨大肿瘤,术后常规膀胱灌注,5例接受系统性化疗。每3个月行膀胱镜检查,必要时再次行TUR-BT手术或全膀胱切除术。结果:术后病理结果均为膀胱癌。随访3-72月,18例存活5年以上。在所有病例中,4例术后1年内死于肿瘤转移,8例无瘤生存,17例术后1-3年复发。复发病例中14例再次或多次行TUR-BT手术,2例行全膀胱切除术,1例行单纯尿流改道手术。结论:经尿道切除膀胱多发肿瘤和巨大肿瘤可以获得较好的治疗效果,根治性TUR-BT辅以系统性化疗或许是膀胱多发肿瘤和/或巨大肿瘤而又希望保留膀胱的病人的理性选择。 Objective: To explore the therapeutic efficiency of transurethral resection of multiple and/or huge blad- der tumor. Methods: Twenty - nine patients with multiple and/or huge bladder tumor were treated with transurethral resection of bladder tumor(TUR - BT) and administered routine intravesical irrigation therapy after operation, while only 5 of them accepted postoperative systemic chemotherapy. All patients were investigated with cystoscope every 3 months and underwent a second TUR - BT or total cystectomy if necessary. Results : The pathological outcomes were carcinoma in all cases. All patients were followed up for 3 -72 months and 18 of them were survived for more than 5 years. Of all,4 cases died of metastasis within 1 year after operation,8 cases were survival without tumor recurrence or metastasis, 17 cases were intravesical recurrence at 1 - 3 year after operation. Of the recurrent cases, 14 cases under- went second or more times TUR - BT,2 cases underwent a total cystectomy, 1 case underwent a urinary diversion op- eration simply. Conclusion:Transurethral resection of multiple and/or huge bladder tumor has good therapeutic effi- ciency. Radical TUR - BT combined with systemic chemotherapy may be a rational selection for patients who suffered multiple and/or huge bladder tumor but desired to reserve bladders.
出处 《现代肿瘤医学》 CAS 2013年第12期2742-2743,共2页 Journal of Modern Oncology
基金 四川省卫生厅基金资助项目(编号:110318)
关键词 经尿道膀胱肿瘤切除 多发膀胱肿瘤 巨大膀胱肿瘤 transurethral resection of bladder tumor multiple bladder tumor huge bladder tumor
  • 相关文献

参考文献10

  • 1Brausi MA. Primary prevention and early detection of bladder canc- er: two main goals for urologists [ J ]. Eur Urol,2013,63 (2) :242 - 243.
  • 2Apolo AB, Grossman HB, Bajorin D, et al. Practical use of perioper- ative chemotherapy for muscle - invasive bladder cancer : summary of session at the Society of Urologic Oncology Annual Meeting[ J]. Urol Oncol,2012,30(6) :772 -780.
  • 3刘先东,吴斌.经尿道膀胱肿瘤切除术治疗膀胱多发肿瘤的疗效观察[J].医学临床研究,2010,27(4):596-597. 被引量:3
  • 4王晓天,宋永胜,崔军.TUR-BT术后行表柔比星、吉西他滨序贯膀胱灌注治疗非肌层浸润性膀胱癌的临床观察[J].现代肿瘤医学,2012,20(11):2328-2330. 被引量:21
  • 5Malkhasyan KA, Ulyanin MY. The value of the preoperative FISH test in unscreened bladder cancer patients with TUR indications [ J}. Pathol Oncol Res ,2012,18 (4) : 1059 - 1066.
  • 6Tsutomu H,Yasutomo S, Yuji T, et al. Efficacy of transurethral re- section of the bladder tumor( TUR - BT) for huge bladder cancer [J]. J Nippon Med Sci,2010,77(4):190- 194.
  • 7Ishioka J, Kageyama Y, Ichiyanagi N, et al. Bladder preservation by chemoradiotherapy in combination with radical TUR - BT in muscle invasive bladder cancer [ J ]. Nihon Hinyokika Gakkai Zasshi, 2007,98(6) :752 -756.
  • 8Fujikawa A, Yumura Y,Yao M, et al. An evaluation to define the role of repeat transurethral resection in a treatment algorithm for non - muscle - invasive bladder cancer[ J]. Indian J Uro1,2012,28 (3) :267 -270.
  • 9Takaoka E, Matsui Y, Inoue T, et al. Risk factors for intravesical re- currence in patients with high - grade Tl bladder cancer in the sec- ond TUR era[J] Jpn J Clin Oncol,2013,43 (4) :404 -409.
  • 10Orsola A, Cecchini L, Raventos CX, et al. Risk factors for positive findings in patients with high - grade T1 bladder cancer treated with transurethral resection of bladder tumour(TUR) and bacille Calmette - Guerin therapy and the decision for a repeat TUR [ J ]. BJU Int ,2010,105 ( 2 ) :202 - 207.

二级参考文献14

  • 1Grob BM,Macchia RJ.Radical transurethral resection in the management of muscle invasive bladder cancer[J].J Endourol,2001,15(4):419-423.
  • 2Stenzl A,Bartsch G,Rogatsch H.The remnant urothelium after reconstructive bladder surgery[J].Eur Urol,2002,41:124-131.
  • 3吴阶平.吴阶平泌尿外科学[M].济南:山东科学技术出版社,2004.589-591.
  • 4Sheps JA, Ling V. Preface : the concept and consequences of multi- drug resistance [ J ]. Pflugers Arch, 2007,453 ( 5 ) : 545 - 553.
  • 5Hoffmann AC, Wild P, Leicht C, et al. MDR1 and ERCCI expres- sion predict outcome of patients with locally advanced bladder cancer receiving adjuvant chemotherapy [ J ]. Neoplasia, 2010, 12 (8) :628 -636.
  • 6李锋,曾顺生.表柔比星术后膀胱灌注防治非肌层浸润性膀胱癌术后复发的疗效观察[J].湖南医学院学报,2011,17(7):942-944.
  • 7Schmorl P, Heer - Sonderhoff A, Vosshenrich R, et al. Cerebral vas- culitis associated with gemcitabine [ J ]. Urologe A, 2010,49 ( 2 ) :268 -270.
  • 8陈旭升,孙光,娄越亮,姚欣.膀胱移行细胞癌组织TGF-β1和细胞周期调控因子表达及其意义的研究[J].中华肿瘤防治杂志,2008,15(11):836-839. 被引量:9
  • 9吴志平,赵晓昆.肾盂输尿管癌并膀胱癌的误诊误治分析(附5例报告)[J].中国现代医学杂志,2009,19(7):1111-1112. 被引量:2
  • 10杜林栋,王文营.膀胱癌相关问题探讨[J].中华临床医师杂志(电子版),2009,3(7):5-8. 被引量:4

共引文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部